Work

Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies

Year: 2009

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2009.01.018

Authors: Kimberly A. Chianese-Bullock, Sarah T. Lewis, Nicholas E. Sherman, John D. Shannon, Craig L. Slingluff

Institutions: University of Virginia Medical Center, University of Virginia, University of Virginia Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Commonwealth Foundation, University of Virginia, UVA Cancer Center, National Cancer Institute

Awards: MULTI-EPITOPE MELANOMA PEPTIDE VACCINATION WITH GM-CSF, VACCINES WITH MHC CLASS II-RESTRICTED MELANOMA PEPTIDES, MULTI-EPITOPE MELANOMA VACCINES FOR CD4 AND CD8 T-CELLS, PEPTIDE BASED VACCINES FOR STAGE IV MELANOMA, Melanoma vaccines using MHC-associated peptides, Multi-peptide Vaccine Administered with Cyclophosphamide for High-risk Melanoma, University of Virginia Cancer Center Support Grant

OpenAlex ID: W1997341897

FWCI: 0.853

Cites: 19

Cited by: 25

Related to: 10